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Abstract 
 
Airborne fungi are ubiquitous in the environment and human exposure is inevitable. 
Such fungi differ greatly in their taxonomic, physical, ecological and pathogenic 
characteristics. Currently, 69 000 species have been taxonomically classified and more 
than 80 of these are recognised to be aeroallergen sources. Many strategies have 
evolved to sample, identify and interpret fungal exposure to these species, however no 
strategy serves all purposes as exposure is a complex and dynamic process confounded 
by spatial, temporal and geographic variations in airborne counts, in addition to the 
inadequacies of the immunodiagnostic techniques available. To date, the interpretation 
of personal exposure and sensitisation to fungal allergens has been restricted to a few 
select species and the contribution of other genera, airborne hyphae and fragmented 
conidia to allergic disease are all poorly understood. The aim of the thesis was to utilize 
the Halogen Immunoassay (HIA) to diagnose fungal allergic sensitisation, to investigate 
the distribution and factors influencing allergens of fungi in the air and to understand 
what is actually inhaled in exposure settings. The novelty of the HIA derives from its 
unique ability to provide allergen sources that are actively secreted by the collected 
fungal spores and hyphae, which are bound to protein binding membranes (PBM) and 
then immunoprobed. 
 In Chapter 2, the HIA was compared to the commercial in vitro Pharmacia 
UniCap assay (CAP) and the in vivo skin prick test (SPT), using 30 sera from subjects 
SPT positive to Aspergillus fumigatus and/or Alternaria alternata and 30 who were SPT 
negative to these fungi but sensitised to non-fungal allergens. Sera were analysed by 
CAP and the HIA against A. alternata, A. fumigatus, Cladosporium herbarum and 
Epicoccum purpurascens and compared statistically. Between 3% and 7% of SPT 
negative sera were identified to have specific IgE towards A. fumigatus and A. 
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alternata, respectively. For the SPT positive sera, significant associations were found 
between the HIA and CAP scores for all fungal species tested (P<0.0001). Correlations 
between the HIA and SPT however, were weakly correlated for A. alternata (rs = 0.44, 
P<0.05) but not for A. fumigatus.  
In Chapter 3, personal exposure to indoor fungal aerosols was examined using 
the HIA to identify the fungal components that people were allergic to. Personal air 
sampling pumps (PASs) collected airborne fungal propagules onto PBMs for 2.5 hours 
indoors (n=21). Collected fungi were incubated overnight in a humid chamber to 
promote the germination of conidia. The membranes were then immunostained with 
pooled human Alternaria species-positive sera. All air samples contained fungal hyphae 
that expressed soluble allergens and were significantly higher in concentration than 
counts of conidia of individual well-characterised allergenic genera. Approximately 
25% of all hyphae expressed detectable allergen compared to non-stained hyphae 
(P<0.05) and the resultant localisation of immunostaining was heterogeneous among 
hyphae. Fungal conidia of ten genera that were previously uncharacterised as allergen 
sources accounted for 8% of the total conidia that demonstrated IgE binding.  
In Chapter 4, the number and identity of fungi inhaled by 34 adults in an outdoor 
community setting was measured over 2 hour periods by people wearing Intra-nasal air 
samplers (INASs) and compared to fungal counts made with a Burkard spore trap and 
filter air samplers worn on the lapel. Using INAS, the most prevalent fungi inhaled 
belonged to soil borne spores of Alternaria, Arthrinium, Bipolaris, Cladosporium, 
Curvularia, Epicoccum, Exserohilum, Fusarium, Pithomyces, Spegazzinia, Tetraploa 
and Xylariaceae species, in addition to hyphal fragments. These results showed that 
inhaled exposure in most people varied in a 2-fold range with 10-fold outliers. In 
addition, the INAS and personal air filters agreed more with each other than with 
Burkard spore trap counts. The analysis was further confounded by different sampling 
efficiencies, locations of devices and ability to visualise and count fungal propagules.  
In Chapter 5, a double immunostaining technique based on the HIA was 
developed and applied to the conidia, hyphae and fungal fragments of A. alternata, A. 
fumigatus and Penicillium chrysogenum to discriminate between sources of allergens, 
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using IgE and to identify the fungi, using a fungal-specific antibody. The localisation of 
immunostaining was heterogeneous between both conidia and the state of germination 
with greater concentrations of double immunostaining detected following germination 
for each fungal species (P<0.0001). Fragmented A. alternata hyphae and 
morphologically indiscernible fragments could be identified for the first time using this 
technique.  
 In Chapter 6, the factors affecting the release of allergen from the spores of 
eleven different species were studied. For nine of eleven species, between 5.7% and 
92% of spores released allergen before germination. Ungerminated spores of P. 
chrysogenum and Trichoderma viride did not release detectable allergen. After 
germination, all spores that germinated eluted allergen from their hyphae. Upon 
germination there was a significant increase in the percentage of spores eluting 
detectable allergen (P<0.0001) and the localisation of allergen along the hyphae varied 
between species. Increased elution of allergen post germination might be a common 
feature of many species of allergenic fungi following inhalation. Additionally, Chapter 
6 explored the extent to which inhaled spores or hyphae germinate after deposition in 
the nasal cavity and thus cause exposure to allergens. Twenty subjects had their noses 
lavaged at three separate intervals, (1) at the beginning of the experiment, (2) after one 
hour indoors and (3) after one hour outdoors. The recovery of spores and hyphal 
fragments from the nasal cavity varied between individuals and was significantly 
greater after outdoor exposures. Germinated fungal spores were recovered often in high 
concentrations for Aspergillus-Penicillium species, however the proportion between 
ungerminated and germinated spores were much lower for other genera recovered.  
Conclusions: Our analysis of cultured and wild-type fungi presents a new paradigm of 
natural fungal exposure, which in addition to commonly recognized species, implicates 
airborne hyphae, fragmented conidia and the conidia of a much more diverse range of 
genera as airborne allergens. Exposure is heterogeneous between individuals in the 
same geographic locality and the spectrum of fungal genera inhaled differs with the 
method of analysis. Many of the spores inhaled are likely to be allergenic, however 
upon germination there is an increased elution of allergen and this might be a common 
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feature of many fungal species following inhalation. This project also provides novel 
techniques to diagnose fungal allergy by immunostaining wild-type fungi to which a 
patient is exposed with the patient’s own serum. Such an immunoassay combines 
environmental with serological monitoring on a patient specific basis and potentially 
avoids many problems associated with extract variability, based on the performance of 
current diagnostic techniques for fungal allergy. 
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1. Green BJ, Mitakakis TZ, Tovey ER. Allergen detection from 11 fungal species 
before and after germination. Journal of Allergy & Clinical Immunology. 2003; 111: 
285-289.  
Abstract 
Background: Allergens dispersed by airborne fungal spores play an important, but 
poorly understood role in the aetiology and exacerbation of asthma. Previous studies 
suggest that after germination, spores of Alternaria and Aspergillus release greater 
quantities of allergen than before germination. It is unknown if this is true of other 
allergenic fungi.  
Objective: Our purpose was to investigate the release of allergen from a range of 
individual fungal spores before and after germination.  
Methods: Allergen expression from spores of Alternaria alternata, Cladosporium 
herbarum, Aspergillus fumigatus, Botrytis cinerea, Epicoccum nigrum, Exserohilum 
rostratum, Penicillium chrysogenum, Stemphylium botryosum, Curvularia lunata, 
Trichoderma viride and Bipolaris spicifera was examined by Halogen immunoassays, 
using pooled serum IgE from fungal-allergic subjects. Spores were deposited onto 
protein binding membranes direct from culture. To germinate spores, samples were 
incubated in high humidity at room temperature for 48 hours. Ungerminated and 
germinated samples were then laminated with an adhesive film and immunostained by 
the Halogen assay. The samples were examined by light microscopy and positive counts 
(haloed particles) were expressed as percentages of total spores. 
Results: For 9 of 11 species, between 5.7 - 92% of spores released allergen before 
germination. Spores of Penicillium and Trichoderma did not release detectable allergen. 
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After germination, all spores that germinated exhibited allergen elution from their 
hyphae. 8 of 11 species showed a significant increase (p<0.05) in the percentage of 
spores eluting detectable allergen. Localization of allergen along the hyphae varied with 
species, such that some eluted allergen mainly from hyphal tips and septal junctions, 
whereas others eluted allergen along the entire length.  
Conclusions: Increased elution of allergen following germination may be a common 
feature of many species of allergenic fungi. Although allergens from both spores and 
hyphae were recognised by human IgE, the extent that human ‘exposure’ occurs to 
allergens eluted from inhaled spores or from hyphae that germinate following 
deposition in the respiratory tract, remains to be explored. The patterns of allergen 
expression may affect the clinical response to such exposure.  
 
2. Green BJ, Sercombe JK, Tovey ER. Fungal fragments and undocumented conidia 
function as new aeroallergen sources. Journal of Allergy & Clinical Immunology. 2005; 
115 (5): 1043-1048.  
Abstract 
Background: More than 100 genera of fungal conidia are currently recognized as 
sources of allergens. The contribution of other fungal genera plus airborne fungal 
hyphae and fragmented conidia to allergic diseases is poorly understood.  
Objective: We sought to investigate the expression of allergens from airborne wild-type 
fungi using the Halogen immunoassay, which uses allergic serum IgE to immunostain 
immobilized allergens extracted from individual fungal particles. 
Methods: Airborne fungi were collected onto mixed cellulose ester protein–binding 
membranes for 2.5 hours with volumetric air pumps. Collected fungi were incubated 
overnight in a humid chamber to promote the germination of conidia. The membranes 
were laminated with an adhesive cover slip and immunostained with an Alternaria 
species–sensitive serum IgE pool. The samples were examined by means of light 
microscopy, and positively immunostained fungal particles were classified and counted. 
Results: All air samples contained fungal hyphae that expressed soluble allergens and 
were significantly higher in concentration than counts of conidia of individual well-
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characterized allergenic genera (P<0.05). Resultant immunostaining of fungal hyphae 
was heterogeneous, and approximately 25% of all hyphae expressed detectable allergen 
compared with nonstained hyphae (P<0.05). Fungal conidia of 10 genera that were 
previously uncharacterized as allergen sources were shown to demonstrate IgE binding 
to expressed antigens and accounted for 8% of the total airborne conidia count. 
Conclusions: Our analysis of wild-type fungi collected indoors presents a new 
paradigm of natural fungal exposure, which, in addition to commonly recognized 
species, implicates airborne hyphae, fragmented conidia, and the conidia of a much 
more diverse range of genera as airborne allergens. 
 
3. Tovey ER, Green BJ. Measuring environmental fungal exposure. Medical 
Mycology. 2005; 43 (suppl 1): 67-70.   
Abstract 
Airborne fungi are ubiquitous in the environment and human exposure is inevitable. 
Such fungi differ greatly in their taxonomic, physical, ecological, behavioural, and 
pathogenic characteristics. Many strategies have evolved to sample, identify and 
interpret fungal exposure and their choice is determined by the hypotheses involved. 
While fungi can be sampled directly from surfaces, results do not generally reflect 
human exposure. For this reason, airborne spores are commonly sampled, by either 
filtration or impaction, using volumetric air samplers. Identification is commonly 
performed by either culture on nutrient medium or light microscopy using 
morphological criteria, although new techniques using DNA probes or characteristic 
antigens or toxins continue to be developed. Interpretation of such exposure data is both 
complex and contentious, but while there are numerous recommendations there is no 
consensus on exposure thresholds. A better understanding of the complex pathogenic 
roles of fungi and susceptibilities of their hosts will enable refinement of techniques for 
sampling and interpretation. 
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4. Green BJ, Schmechel D, Tovey ER. Detection of Alternaria alternata conidia and 
hyphae using a novel double immunostaining technique. Clinical and Diagnostic 
Laboratory Immunology, 12 (9): 1114-1116. 
Abstract 
A double immunostaining Halogen immunoassay was developed to identify aerosolized 
conidia, hyphae and fragments of Alternaria alternata using an anti-Alternaria 
polyclonal antiserum, while simultaneously, allergy to these components was 
concurrently determined using human IgE antibodies. 
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